Dioxinodehydroeckol, eckol, phlorofurofucoeckol-A |
|
E. bicyclis
|
Inhibition of BACE1 |
In vitro |
In vitro assay |
[209] |
Fucofuroeckol-b |
25–100 µg/mL |
E. bicyclis
|
Inhibition of β-secretase |
In vitro |
Aβ-induced toxicity on SH-SY5Y cells overexpressing APP695swe (parameters assessed: cell viability and expression levels of sAPPβ and Aβ42) |
[210] |
Eckol and dieckol
|
|
E. bicyclis
|
Inhibition of hMAOs |
In vitro |
In vitro assay |
[212] |
Phlorofucofuroeckol-A |
|
E. stolonifera
|
Inhibition of hMAOs |
In vitro |
In vitro assay |
[213] |
6, 6′-Bieckol
|
10–40 µM |
E. stolonifera
|
Anti-inflammatory |
In vitro |
LPS-stimulated BV2 and murine primary microglial cells (parameters assessed: cell viability, intracellular ROS, levels of pro-inflammatory mediators, activation of signalling pathways) |
[364] |
Diphlorethohydroxycarmalol
|
0.5–50 µM |
I. okamurae
|
Antioxidant |
In vitro |
HT22 cells treated by H2O2 (parameters assessed: cell viability, apoptosis, intracellular ROS, lipid peroxidation inhibitory activity, and intracellular Ca2+ level) |
[367] |
Different extracts containing phloroglucinol and other phenolic compounds |
|
H. elongata
|
Antioxidant |
In vitro |
DPPH• scavenging activity |
[369] |